Health Coverage Interruptions Common in Adults With T1DM

Share this content:
Health Coverage Interruptions Common in Adults With T1DM
Health Coverage Interruptions Common in Adults With T1DM

MONDAY, July 30, 2018 (HealthDay News) -- Interruptions in private health insurance coverage are common among U.S. adults with type 1 diabetes and are associated with an increase in glycated hemoglobin and in use of acute care services, according to a report published in the July issue of Health Affairs.

In a longitudinal study, Mary A.M. Rogers, Ph.D., from the University of Michigan in Ann Arbor, and colleagues examined the frequency of interruptions in private health insurance and associated outcomes for working-age U.S. adults with type 1 diabetes in 2001 to 2015. Data were included for a sample of 168,612 adults (ages 19 to 64 years) with type 1 diabetes who had 2.6 mean years of insurance coverage overall.

The researchers found that 24.3 percent of the adults experienced an interruption in coverage. There was a 3.6 percent relative increase in glycated hemoglobin for each interruption. After an interruption in health insurance, the use of acute care services was five-fold greater than before the interruption; use remained elevated when stratified by age, sex, or diabetic complications. Lower perceived health status and lower satisfaction with life were associated with an interruption.

"We conclude that interruptions in private health insurance are common among adults with type 1 diabetes and have serious consequences for their well-being," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »